Major Depressive Disorder In The Elderly

• Status: Completed
• Trial end date: 2005-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a placebo-controlled study evaluating the effectiveness of medication in elderly subjects with Major Depressive Disorder (MDD).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Bupropion

Criteria

Inclusion Criteria:

• Primary diagnosis of Major Depressive Disorder with DSM-IV criteria for their current episode for at least 8 weeks.

Exclusion Criteria:

• Patient has current or past history of seizure disorder or brain injury.

• Patient has a diagnosis of anorexia or bulimia within the past 12 months.

• Patient has a past or current DMS-IV diagnosis of schizophrenia or any other psychotic disorder(s).

• Patient has had a myocardial infarction within 1 year or a history of uncontrolled hypertension or unstable heart disease with 6 months.